Cytosorbents (CTSO) Other Non Operating Income (2015 - 2026)

Cytosorbents' Other Non Operating Income history runs 12 years deep, the most recent figure standing at -$1.2 million for Q1 2026.

• Quarterly Other Non Operating Income fell 140.74% year-over-year to -$1.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.1 million (up 2262.33% YoY) and the FY2025 annual result came in at $9.3 million, up 320.62% from the prior year.
• Other Non Operating Income was -$1.2 million for Q1 2026 at Cytosorbents, down from $193000.0 in the prior quarter.
• Across five years, Other Non Operating Income topped out at $6.2 million in Q2 2025 and bottomed at -$4.9 million in Q4 2024.
• A 5-year average of $198175.6 and a median of -$64000.0 in 2025 frame the typical range for Other Non Operating Income.
• Annual changes were most pronounced in 2022 — Other Non Operating Income slumped 1177.6% — and 2025, when it soared 1235.66%.
• Cytosorbents' Other Non Operating Income stood at $4.5 million in 2022, then plunged by 40.61% to $2.7 million in 2023, then plunged by 282.8% to -$4.9 million in 2024, then surged by 103.93% to $193000.0 in 2025, then sank by 736.27% to -$1.2 million in 2026.
• Business Quant data shows CTSO's Other Non Operating Income at -$1.2 million in Q1 2026, $193000.0 in Q4 2025, and -$64000.0 in Q3 2025.